These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36700398)

  • 1. Duality of Nrf2 in iron-overload cardiomyopathy.
    Federti E; Vinchi F; Iatcenko I; Ghigo A; Matte A; Toya SCM; Siciliano A; Chiabrando D; Tolosano E; Vance SZ; Riccardi V; Andolfo I; Iezzi M; Lamolinara A; Iolascon A; De Franceschi L
    Haematologica; 2023 May; 108(5):1335-1348. PubMed ID: 36700398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced iron-overload cardiomyopathy in a genetic murine model is rescued by resveratrol therapy.
    Das SK; Zhabyeyev P; Basu R; Patel VB; Dyck JRB; Kassiri Z; Oudit GY
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29208771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Females Are Protected From Iron-Overload Cardiomyopathy Independent of Iron Metabolism: Key Role of Oxidative Stress.
    Das SK; Patel VB; Basu R; Wang W; DesAulniers J; Kassiri Z; Oudit GY
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28115312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
    Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
    Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and treatment of cardiac iron overload in transfusion-dependent thalassemia patients.
    Siri-Angkul N; Chattipakorn SC; Chattipakorn N
    Expert Rev Hematol; 2018 Jun; 11(6):471-479. PubMed ID: 29754517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astragalus polysaccharide upregulates hepcidin and reduces iron overload in mice via activation of p38 mitogen-activated protein kinase.
    Ren F; Qian XH; Qian XL
    Biochem Biophys Res Commun; 2016 Mar; 472(1):163-8. PubMed ID: 26915800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription factor NRF2 protects mice against dietary iron-induced liver injury by preventing hepatocytic cell death.
    Silva-Gomes S; Santos AG; Caldas C; Silva CM; Neves JV; Lopes J; Carneiro F; Rodrigues PN; Duarte TL
    J Hepatol; 2014 Feb; 60(2):354-61. PubMed ID: 24021424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver expression of hepcidin and other iron genes in two mouse models of beta-thalassemia.
    De Franceschi L; Daraio F; Filippini A; Carturan S; Muchitsch EM; Roetto A; Camaschella C
    Haematologica; 2006 Oct; 91(10):1336-42. PubMed ID: 17018382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiomyopathy associated with iron overload: how does iron enter myocytes and what are the implications for pharmacological therapy?
    Wijarnpreecha K; Kumfu S; Chattipakorn SC; Chattipakorn N
    Hemoglobin; 2015; 39(1):9-17. PubMed ID: 25572185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mRNA expression of iron regulatory genes in beta-thalassemia intermedia and beta-thalassemia major mouse models.
    Weizer-Stern O; Adamsky K; Amariglio N; Rachmilewitz E; Breda L; Rivella S; Rechavi G
    Am J Hematol; 2006 Jul; 81(7):479-83. PubMed ID: 16755567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of hepcidin gene expression in blood mononuclear cells with iron overload severity among β-thalassemia major patients.
    Ayatollahi H; Mousavi Nezhad SF; Talebpour A; Badiei Z; Nezami H
    Mol Biol Rep; 2020 Dec; 47(12):9353-9359. PubMed ID: 33231816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron and oxidative stress in cardiomyopathy in thalassemia.
    Berdoukas V; Coates TD; Cabantchik ZI
    Free Radic Biol Med; 2015 Nov; 88(Pt A):3-9. PubMed ID: 26216855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia.
    Schmidt PJ; Toudjarska I; Sendamarai AK; Racie T; Milstein S; Bettencourt BR; Hettinger J; Bumcrot D; Fleming MD
    Blood; 2013 Feb; 121(7):1200-8. PubMed ID: 23223430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of iron overload condition on liver toxicity and hepcidin/ferroportin expression in thalassemic mice.
    Kumfu S; Chattipakorn SC; Fucharoen S; Chattipakorn N
    Life Sci; 2016 Apr; 150():15-23. PubMed ID: 26921633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepcidin knockout mice spontaneously develop chronic pancreatitis owing to cytoplasmic iron overload in acinar cells.
    Lunova M; Schwarz P; Nuraldeen R; Levada K; Kuscuoglu D; Stützle M; Vujić Spasić M; Haybaeck J; Ruchala P; Jirsa M; Deschemin JC; Vaulont S; Trautwein C; Strnad P
    J Pathol; 2017 Jan; 241(1):104-114. PubMed ID: 27741349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron overload induces dysplastic erythropoiesis and features of myelodysplasia in Nrf2-deficient mice.
    Duarte TL; Lopes M; Oliveira M; Santos AG; Vasco C; Reis JP; Antunes AR; Gonçalves A; Chacim S; Oliveira C; Porto B; Teles MJ; Moreira AC; Silva AMN; Schwessinger R; Drakesmith H; Henrique R; Porto G; Duarte D
    Leukemia; 2024 Jan; 38(1):96-108. PubMed ID: 37857886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac complications in beta-thalassemia: From mice to men.
    Kumfu S; Fucharoen S; Chattipakorn SC; Chattipakorn N
    Exp Biol Med (Maywood); 2017 Jun; 242(11):1126-1135. PubMed ID: 28485683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TIMP3 deficiency exacerbates iron overload-mediated cardiomyopathy and liver disease.
    Zhabyeyev P; Das SK; Basu R; Shen M; Patel VB; Kassiri Z; Oudit GY
    Am J Physiol Heart Circ Physiol; 2018 May; 314(5):H978-H990. PubMed ID: 29373036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver sinusoidal endothelial cells induce BMP6 expression in response to non-transferrin-bound iron.
    Charlebois E; Fillebeen C; Presley J; Cagnone G; Lisi V; Lavallée VP; Joyal JS; Pantopoulos K
    Blood; 2023 Jan; 141(3):271-284. PubMed ID: 36351237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nrf2 expression and function, but not MT expression, is indispensable for sulforaphane-mediated protection against intermittent hypoxia-induced cardiomyopathy in mice.
    Zhou S; Wang J; Yin X; Xin Y; Zhang Z; Cui T; Cai J; Zheng Y; Liu Q; Cai L
    Redox Biol; 2018 Oct; 19():11-21. PubMed ID: 30096613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.